Research
Engaging Research to Achieve Cancer Care Equity
ERACE Research Award
ConcertAI is sponsoring the Engaging Research to Achieve Cancer Care Equity (ERACE) Research Award. This award will provide early-stage career research investigators with monetary support and access to one of the most comprehensive cancer patient datasets available for research purposes in the United States.
The award is intended to support research aimed at examining potential differences in treatment patterns, outcomes, clinical practice, genomics, safety, and other issues related to cancer care among populations with existing disparities, particularly those that exist among racial and ethnic groups, which could inform strategies to eliminate cancer health disparities. The award will be granted based on individual merit and the candidate’s potential for long term impact in cancer disparity research.
Learn More and Applyasco quality care symposium
Racial Disparities in Performance Status
A new study by ConcertAI based on patient-reported outcomes makes another compelling case for addressing disparities in treatment outcomes and racially biased access to clinical trials – and for why a new research focus is imperative.
See Full StudyMethods
Retrospective Study of Self-Assessed Performance Status (ECOG)
Background
- Clinical trials lack adequate number of racial minorities.
- Performance status often a criterion for clinical research.
- Poor performance status can exclude patients from clinical trial participation.
Patient in Study
- 55.4% White
- 38.0% Black
Results
Black patients overall reported higher average ECOG scores and greater difficulty performing daily functions than White patients.
Patients reporting not being able to take care of themselves
Blacks
Whites
Conclusion
Mission
ERACE is part of ConcertAI’s commitment to move beyond descriptions of differences in cancer outcomes towards achievement of cancer health equity by funding innovative research and technologies across the care continuum in order to drive more equitable care and associated outcomes and make a meaningful difference in the lives of patients from underrepresented backgrounds.
Use RWD for Insights into Health Disparities
Rethink Research Questions
Redesign Studies
Change How Clinical Trials are Run
Patient Registry
The ERACE Patient Registry is foundational to its mission of eliminating inequities.
The registry provides a real-world view of potential differences in clinical practice, patient outcomes, safety, and comparative effectiveness among cancer patients of color and other marginalized groups.






Learn more about ERACE